Aratana Therapeutics (PETX) AT-001 Top-Line Canine Osteoarthritis Study Results |
Posted: December 18, 2014 |
Aratana Therapeutics, Inc. (PETX) reported positive results from its pivotal field study of AT-001 (Grapiprant), its innovative drug for treating pain in dogs with osteoarthritis
|
|||||||||||||||||||||||||||||||||||||||
|